Medical Journals

Ischemic Postconditioning During Reperfusion Activates Akt and Erk Without Protecting Against Lethal Myocardial Ischemia-reperfusion Injury in Pigs.

Authors:
  • Schwartz Lisa M
  • Lagranha Claudia J

From: Department of Anatomy, Physiology, and Genetics, Uniformed Services Univ. of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, Maryland 20814-4799, USA. lschwartz@usuhs.mil

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Mar 2006
  • ISSN: 0363-6135
  • Volume: 290
  • Issue: 3
  • Pages: H1011-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Schwartz Lisa M, Lagranha Claudia J, et al. Ischemic Postconditioning During Reperfusion Activates Akt and Erk Without Protecting Against Lethal Myocardial Ischemia-reperfusion Injury in Pigs.. Am. J. Physiol. Heart Circ. Physiol. Mar 2006;290:H1011-8

Abstract

Transient episodes of ischemic preconditioning (PC) render myocardium protected against subsequent lethal injury after ischemia and reperfusion. Recent studies indicate that application of short, repetitive ischemia only during the onset of reperfusion after the lethal ischemic event may obtain equivalent protection. We assessed whether such ischemic postconditioning (Postcon) is cardioprotective in pigs by limiting lethal injury. Pentobarbital sodium-anesthetized, open-chest pigs underwent 30 min of complete occlusion of the left anterior descending coronary artery and 3-h reflow. PC was elicited by two cycles of 5-min occlusion plus 10-min reperfusion before the 30-min occlusion period. Postcon was elicited by three cycles of 30-s reperfusion, followed by 30-s reocclusion, after the 30-min occlusion period and before the 3-h reflow. Infarct size (%area-at-risk using triphenyltetrazolium chloride macrochemistry; means +/- SE) after 30 min of ischemia was 26.5 +/- 5.2% (n = 7 hearts/treatment group). PC markedly limited myocardial infarct size (2.8 +/- 1.2%, n = 7 hearts/treatment group, P < 0.05 vs. controls). However, Postcon had no effect on infarct size (37.8 +/- 5.1%, n = 7 hearts/treatment group). Within the subendocardium, Postcon increased phosphorylation of Akt (74 +/- 12%) and ERK1/2 (56 +/- 10%) compared with control hearts subjected only to 30-min occlusion and 15-min reperfusion (P < or = 0.05), and these changes were not different from the response triggered by PC (n = 5 hearts/treatment group). Phosphorylation of downstream p70S6K was also equivalent in PC and Postcon groups. These data do not support the hypothesis that application of 30-s cycles of repetitive ischemia during reperfusion exerts a protective effect on pig hearts subjected to lethal ischemia, but this is not due to a failure to phosphorylate ERK and Akt during early reperfusion.

Mesh Headings (Keywords): Animals, Enzyme Activation, Extracellular Signal-Regulated MAP Kinases, Female, Ischemic Preconditioning, Myocardial, Male, Oncogene Protein v-akt, Reperfusion Injury, Survival Rate, Swine, Treatment Outcome


Check for Full Text / PubMed Unique Identifier (PMID): 16214840


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.